If the high court were to uphold the ruling handed down by U.S. Judge Matthew J. Kacsmaryk in Texas, it could give courts the power to invalidate almost any FDA approval, scholars warn. This could lead to uncertainty in the pharmaceutical industry, with manufacturers not assured of a uniform market for their drugs based on FDA approval.
Abortion Drug Approval in Limbo: Legal Battle Heats Up in Washington State
